Hillevax

2 followers

‌

HilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccines. Their initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infecti... Read more

Industries

Headquarters

Employees

Links

Org chart

Rob Hershberg
CEO, President & Chair

Rob Hershberg

Collapse
Shane Maltbie
Chief Financial Officer
Astrid Borkowski
Chief Medical Officer
Paul Bavier
General Counsel, Secretary & Chief Administrative Officer
Tomoe Felder
Director, Strategy And Operations, Chief Medical Office
Ozzie Berger
Senior Vice President
Christopher Aakre, PhD
Vice President, Program Management
Holger Koch
VP Analytical Research & Development
Shannon Harris
Vice President, Head Of Clinical Assays
Tara Raab
Vice President Of Quality
Anju Chatterji
Chief Technology Officer
Wendy T.
VP, Head of Clinical Operations
Qi Li
Director, Research & Pre-clinical Development